Amita Shukla is an innovator and entrepreneur focused on creating and scaling transformative innovations for human health, well-being, and potential. She is the founder and CEO of Vitamita and the author of Enduring Edge: Transforming How We Think, Create and Change. Previously, she spent close to nine years at New Enterprise Associates (NEA), one of the world’s largest and most active venture capital firms with about $17 billion in committed capital, where she evaluated and invested in cutting edge medical innovations and worked closely with scientists, physicians, and entrepreneurs to build new healthcare companies. Earlier, she was the vice president of AmiKa Corp., a biomedical technology company where she developed and commercialized novel research tools–for which she holds 10 issued patents–until its acquisition by Harvard Bioscience (BIO).
Amita regularly mentors startups, advises organizations, and speaks to audiences of innovators, entrepreneurs, and leaders in industry, academia, and government. In 2010, she was Maryland Governor Martin O’Malley’s youngest appointee to the board of the Technology Development Corporation (TEDCO), a national leader in seed/early-stage investing. She was reappointed by Governor Larry Hogan in 2015. Amita previously served on the Johns Hopkins Medicine Alliance for Science and Technology Development and as a Mentor in Residence at Johns Hopkins Technology Ventures to help the institution’s researchers and physicians realize the potential of their groundbreaking discoveries. Amita currently serves on the board of Bethesda Green, as a founding board member of the Global Liver Institute, and on the Life Science Council at Springboard. She holds a BA in biochemistry from Harvard, where she was a senior editor at the Harvard Crimson, and an MBA from Stanford, where she led a team that won the university-wide Stanford business plan competition for a novel cardiovascular device.